Japanese Retailer Aeon Partners With Drug Store Chain Shimizu Yakuhin
This article was originally published in PharmAsia News
Executive Summary
One of Japan's biggest retailers Aeon signed Aug. 8 a capital and business partnership with Kyodo-based drugstore chain Shimizu Yakuhin. According to the agreement, Aeon will acquire 30 percent of Shimizu shares for an undisclosed amount, and the two companies will jointly purchase drug products. (Click here for more - Japanese language) "Aeon Partners With Kyodo Drug Store Chain Shimizu And To Acquire 30 Percent Shimizu Shares" - Jiji Press (8/8/08)
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.